AI Cure is a research tool showing open data. Not medical advice. Discuss with your doctor. Terms

โ† Trials
๐Ÿงช

Effect of Dry Eye Treatment on Corneal Astigmatism Measurements

RecruitingNAAges any - anyAllJin Yang
๐Ÿ’ฌ

In plain words

What the trial is, and whether it could suit you

This prospective single-center study evaluates the effect of dry eye disease and short-term ocular surface treatment on the agreement and repeatability of corneal astigmatism measurements in patients with age-related cataract. Participants undergoing preoperative cataract evaluation are classified into a control group or a dry eye disease group according to ocular surface symptoms and objective tear film findings. All participants undergo ocular surface assessment and repeated corneal measurements using three commonly used devices: IOLMaster 700, Pentacam AXL, and iTrace Prime. Measurements include keratometric corneal astigmatism, total corneal astigmatism, and vector components of astigmatism. Patients with dry eye disease receive 0.3% sodium hyaluronate eye drops four times daily for 2 weeks, after which ocular surface assessment and device measurements are repeated. The primary obj

Sign in to get the eligibility rules as simple questions to take to your doctor.

๐Ÿ“‹ Eligibility rules (as published)
Inclusion Criteria: * Patients with age-related cataract undergoing preoperative ocular examination. * Ability to complete ocular surface evaluation, including the Ocular Surface * Disease Index questionnaire, non-invasive tear film break-up time, tear meniscus height, Schirmer test, and ocular surface staining. * Ability to complete repeated corneal astigmatism measurements using IOLMaster 700, Pentacam AXL, and iTrace Prime. * Ability to maintain stable fixation during device measurements. Provision of written informed consent. Exclusion Criteria: * Previous ocular surgery or ocular trauma. * Corneal degeneration, corneal dystrophy, or other corneal diseases that could affect corneal measurements. * Active corneal or conjunctival infection. * Uveitis. * Use of any topical eye drops within 24 hours before examination. * Use of antiglaucoma medications. * Contact lens wear within 1 month before examination. * Previous or ongoing treatment for dry eye disease. * Poor fixation during device measurements. * Poor-quality measurements from any study device
๐Ÿ’Š

What it tests

  • Sodium Hyaluronate Eye Drops
๐Ÿ“

Where

1 site
Eye and ENT hospital of Fudan University
Shanghai, China
๐Ÿค Taking part is your choice, and you can leave at any time. Only the trial team can confirm you are eligible โ€” always decide together with your own doctor.
๐Ÿ›ก๏ธ

AI Cure shows public evidence (Open Targets, ClinicalTrials.gov, PubMed, openFDA, DepMap, AlphaFold) with its source, and AI summaries that cite it โ€” not medical advice and not a cure. Treatment decisions belong with your doctor. Research ideas are shared only with approved researchers and labs, who can test them. In an emergency call your local emergency number (112 in India and Europe, 911 in the US). AI Cure Terms of Use ยท Privacy